UPDATE : Monday, September 7, 2020
상단여백
‘Favipiravir not approved as new coronavirus drug yet’ by Kim Yun-mi 2020-02-21 12:08
Closures of emergency rooms could hit critical patients hard by Kim Yun-mi 2020-02-20 14:25
Regulator pushed voluntary recall of Belviq without data review by Kim Yun-mi 2020-02-19 11:52
Remdesivir, plasma transfusion emerge as treatment of new coronavirus by Kim Yun-mi 2020-02-18 12:57
International conferences put back due to coronavirus outbreak by Kim Yun-mi 2020-02-13 14:22
라인
Korea University analyzes 5,000 cancer patients’ genomic data  by Kim Yun-mi 2020-02-11 15:49
MSD Korea workers unhappy with spinoff plan by Kim Yun-mi 2020-02-11 14:57
Fake news about new coronavirus drug candidate goes viral by Kim Yun-mi 2020-02-11 12:33
New coronavirus causes less damage, spreads more easily by Kim Yun-mi 2020-02-10 12:32
Experts caution against hasty use of Olumiant for new coronavirus by Kim Yun-mi 2020-02-06 16:08
라인
MSD to spin off women’s health, biosimilars under new firm by Kim Yun-mi 2020-02-06 13:07
Interferon, Kaletra to get insurance benefit for new coronavirus treatment by Kim Yun-mi 2020-02-04 16:39
‘Gilead’s drug candidate effective to fight new coronavirus’ by Kim Yun-mi 2020-02-04 16:39
Merck Korea worker commits suicide by Kim Yun-mi 2020-01-30 16:09
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod by Kim Yun-mi 2020-01-30 14:07
라인
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’ by Kim Yun-mi 2020-01-29 14:00
Afstyla wins nod as new therapy for hemophilia A by Kim Yun-mi 2020-01-24 08:18
SK Chemicals avoids drug price cut using administrative suit by Kim Yun-mi 2020-01-23 15:24
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019 by Kim Yun-mi 2020-01-22 15:10
Some Merck Korea workers commute from provinces to Seoul every day by Kim Yun-mi 2020-01-21 14:21
여백
여백
여백
Back to Top